Medical News: Raptiva Yanked from U.S. Market – in Product Alert, Prescriptions from MedPage Today

Genentech announced a “phased voluntary withdrawal” of the drug beginning immediately, advising physicians to avoid writing prescriptions for new patients and to contact those already on the drug to discuss alternative therapies.

I wonder if  a  “phased voluntary withdrawal” is enough to avoid the lawsuits?